Drew Moghanaki, Professor, Chief of Thoracic Oncology at the Department of Radiation Oncology and Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at David Geffen School of Medicine at UCLA, and Chief Medical Officer of Respirati, shared a post on X:
“A colorful slide and a pontificating Henning Willers to ponder the four randomized clinical trials evaluating SBRT + immunotherapy for stage I NSCLC.”
More posts featuring Drew Moghanaki.